Replies to post #539425 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Thanks Lykiri, I believe these are all different collaborations between UCLA, Merck (Keytruda / Pembrolizumab) and Bristol Meyers Squibb (BMS) (Opdivo / Nivolumab).

Also, I believe the studies are different, some combine DCVax-L + PD-1 inhibitor + CSF-1R inhibitor, and then others also add poly-ICLC

Did you have a chance to view this link?

https://reporter.nih.gov/search/cmeOHFTNlEGR3qDo7Efd5Q/project-details/9983047